These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7151638)

  • 1. Cardiovascular birth defects and antenatal exposure to female sex hormones.
    Hadjigeorgiou E; Malamitsi-Puchner A; Lolis D; Lazarides P; Nicolopoulos D; Kaskarelis D
    Dev Pharmacol Ther; 1982; 5(1-2):61-7. PubMed ID: 7151638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular birth defects and antenatal exposure to female sex hormones.
    Heinonen OP; Slone D; Monson RR; Hook EB; Shapiro S
    N Engl J Med; 1977 Jan; 296(2):67-70. PubMed ID: 830309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neonatal malformations and hormone therapy during pregnancy].
    Pacilli L; Graffino W; Arrotta S
    Minerva Ginecol; 1981; 33(7-8):659-65. PubMed ID: 7290498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comments on "Cardiovascular birth defects and prenatal exposure to female sex hormones".
    Wiseman RA
    Teratology; 1994 Mar; 49(3):172-3; discussion 174-7. PubMed ID: 8059423
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiovascular birth defects and antenatal exposure to female sex hormones: a reevaluation of some base data.
    Wiseman RA; Dodds-Smith IC
    Teratology; 1984 Dec; 30(3):359-70. PubMed ID: 6240131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal hormone therapy and congenital heart disease.
    Ferencz C; Matanoski GM; Wilson PD; Rubin JD; Neill CA; Gutberlet R
    Teratology; 1980 Apr; 21(2):225-39. PubMed ID: 7394725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular birth defects and prenatal exposure to female sex hormones: importance of utilizing proper epidemiological methods and teratologic principles.
    Brent RL
    Teratology; 1994 Mar; 49(3):159-61. PubMed ID: 8059420
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular birth defects and prenatal exposure to female sex hormones: a reevaluation of data reanalysis from a large prospective study.
    Hook EB
    Teratology; 1992 Sep; 46(3):261-6. PubMed ID: 1523583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial: Can the pill cause birth defects?
    Nora JJ; Nora AH
    N Engl J Med; 1974 Oct; 291(14):731-2. PubMed ID: 4851496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exogenous hormones and other drug exposures of children with congenital heart disease.
    Rothman KJ; Fyler DC; Goldblatt A; Kreidberg MB
    Am J Epidemiol; 1979 Apr; 109(4):433-9. PubMed ID: 443241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal drugs and congenital heart disease.
    Zierler S
    Obstet Gynecol; 1985 Feb; 65(2):155-65. PubMed ID: 3881709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogenous sex hormone exposure and the risk for VACTERL association.
    Lammer EJ; Cordero JF; Khoury MJ
    Teratology; 1986 Oct; 34(2):165-9. PubMed ID: 3775669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of the potential teratogenic effect of large doses of promethazine used for a suicide attempt by 32 pregnant women.
    Petik D; Acs N; Bánhidy F; Czeizel AE
    Toxicol Ind Health; 2008; 24(1-2):87-96. PubMed ID: 18818185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population-based case-control study of mebendazole in pregnant women for birth outcomes.
    Acs N; Bánhidy F; Puhó E; Czeizel AE
    Congenit Anom (Kyoto); 2005 Sep; 45(3):85-8. PubMed ID: 16131365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal smoking and congenital heart defects.
    Malik S; Cleves MA; Honein MA; Romitti PA; Botto LD; Yang S; Hobbs CA;
    Pediatrics; 2008 Apr; 121(4):e810-6. PubMed ID: 18381510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placental pathologic conditions in anticardiolipin antibody positive women whose infants had congenital heart defects.
    Kowal-Vern A; Fisher SG; Muraskas J; Jandreski MA; Gianopoulos JG; Husain A
    J Perinatol; 1996; 16(4):268-71. PubMed ID: 8866295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital heart disease and prenatal exposure to exogenous sex hormones.
    Janerich DT; Dugan JM; Standfast SJ; Strite L
    Br Med J; 1977 Apr; 1(6068):1058-60. PubMed ID: 858045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are female sex hormones teratogenic?
    Wilson JG; Brent RL
    Am J Obstet Gynecol; 1981 Nov; 141(5):567-80. PubMed ID: 6271011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal exposure to sex hormones: a case-control study.
    Martínez-Frías ML; Rodríguez-Pinilla E; Bermejo E; Prieto L
    Teratology; 1998 Jan; 57(1):8-12. PubMed ID: 9516746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characteristics of neonates whose mothers have congenital and acquired heart disease].
    Garnizov T; Ivanov S; Dukovski A; Slŭncheva B; Vakrilova L; Georgiev G
    Akush Ginekol (Sofiia); 2002; 42(1):3-6. PubMed ID: 11935697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.